Oral pre-exposure prophylaxis (PrEP) for prevention of HIV in serodiscordant heterosexual couples in the United States: Opportunities and challenges

James M. McMahon, Julie E. Myers, Ann E. Kurth, Stephanie E. Cohen, Sharon B. Mannheimer, Janie Simmons, Enrique R. Pouget, Nicole Trabold, Jessica E. Haberer

Research output: Contribution to journalArticle

Abstract

Oral HIV pre-exposure prophylaxis (PrEP) is a promising new biomedical prevention approach in which HIV-negative individuals are provided with daily oral antiretroviral medication for the primary prevention of HIV-1. Several clinical trials have demonstrated efficacy of oral PrEP for HIV prevention among groups at high risk for HIV, with adherence closely associated with level of risk reduction. In the United States (US), three groups have been prioritized for initial implementation of PrEP - injection drug users, men who have sex with men at substantial risk for HIV, and HIV-negative partners within serodiscordant heterosexual couples. Numerous demonstration projects involving PrEP implementation among MSM are underway, but relatively little research has been devoted to study PrEP implementation in HIV-serodiscordant heterosexual couples in the US. Such couples face a unique set of challenges to PrEP implementation at the individual, couple, and provider level with regard to PrEP uptake and maintenance, adherence, safety and toxicity, clinical monitoring, and sexual risk behavior. Oral PrEP also provides new opportunities for serodiscordant couples and healthcare providers for primary prevention and reproductive health. This article provides a review of the critical issues, challenges, and opportunities involved in the implementation of oral PrEP among HIV-serodiscordant heterosexual couples in the US.

Original languageEnglish (US)
Pages (from-to)462-474
Number of pages13
JournalAIDS Patient Care and STDs
Volume28
Issue number9
DOIs
StatePublished - Sep 1 2014

Fingerprint

Heterosexuality
HIV
Primary Prevention
Pre-Exposure Prophylaxis
Reproductive Health
Risk Reduction Behavior
Risk-Taking
Drug Users
Sexual Behavior
Health Personnel
HIV-1
Maintenance
Clinical Trials
Safety
Injections

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Infectious Diseases

Cite this

Oral pre-exposure prophylaxis (PrEP) for prevention of HIV in serodiscordant heterosexual couples in the United States : Opportunities and challenges. / McMahon, James M.; Myers, Julie E.; Kurth, Ann E.; Cohen, Stephanie E.; Mannheimer, Sharon B.; Simmons, Janie; Pouget, Enrique R.; Trabold, Nicole; Haberer, Jessica E.

In: AIDS Patient Care and STDs, Vol. 28, No. 9, 01.09.2014, p. 462-474.

Research output: Contribution to journalArticle

McMahon, JM, Myers, JE, Kurth, AE, Cohen, SE, Mannheimer, SB, Simmons, J, Pouget, ER, Trabold, N & Haberer, JE 2014, 'Oral pre-exposure prophylaxis (PrEP) for prevention of HIV in serodiscordant heterosexual couples in the United States: Opportunities and challenges', AIDS Patient Care and STDs, vol. 28, no. 9, pp. 462-474. https://doi.org/10.1089/apc.2013.0302
McMahon, James M. ; Myers, Julie E. ; Kurth, Ann E. ; Cohen, Stephanie E. ; Mannheimer, Sharon B. ; Simmons, Janie ; Pouget, Enrique R. ; Trabold, Nicole ; Haberer, Jessica E. / Oral pre-exposure prophylaxis (PrEP) for prevention of HIV in serodiscordant heterosexual couples in the United States : Opportunities and challenges. In: AIDS Patient Care and STDs. 2014 ; Vol. 28, No. 9. pp. 462-474.
@article{4920f598dd204393a5a0772ba2e89ca0,
title = "Oral pre-exposure prophylaxis (PrEP) for prevention of HIV in serodiscordant heterosexual couples in the United States: Opportunities and challenges",
abstract = "Oral HIV pre-exposure prophylaxis (PrEP) is a promising new biomedical prevention approach in which HIV-negative individuals are provided with daily oral antiretroviral medication for the primary prevention of HIV-1. Several clinical trials have demonstrated efficacy of oral PrEP for HIV prevention among groups at high risk for HIV, with adherence closely associated with level of risk reduction. In the United States (US), three groups have been prioritized for initial implementation of PrEP - injection drug users, men who have sex with men at substantial risk for HIV, and HIV-negative partners within serodiscordant heterosexual couples. Numerous demonstration projects involving PrEP implementation among MSM are underway, but relatively little research has been devoted to study PrEP implementation in HIV-serodiscordant heterosexual couples in the US. Such couples face a unique set of challenges to PrEP implementation at the individual, couple, and provider level with regard to PrEP uptake and maintenance, adherence, safety and toxicity, clinical monitoring, and sexual risk behavior. Oral PrEP also provides new opportunities for serodiscordant couples and healthcare providers for primary prevention and reproductive health. This article provides a review of the critical issues, challenges, and opportunities involved in the implementation of oral PrEP among HIV-serodiscordant heterosexual couples in the US.",
author = "McMahon, {James M.} and Myers, {Julie E.} and Kurth, {Ann E.} and Cohen, {Stephanie E.} and Mannheimer, {Sharon B.} and Janie Simmons and Pouget, {Enrique R.} and Nicole Trabold and Haberer, {Jessica E.}",
year = "2014",
month = "9",
day = "1",
doi = "10.1089/apc.2013.0302",
language = "English (US)",
volume = "28",
pages = "462--474",
journal = "AIDS Patient Care and STDs",
issn = "1087-2914",
publisher = "Mary Ann Liebert Inc.",
number = "9",

}

TY - JOUR

T1 - Oral pre-exposure prophylaxis (PrEP) for prevention of HIV in serodiscordant heterosexual couples in the United States

T2 - Opportunities and challenges

AU - McMahon, James M.

AU - Myers, Julie E.

AU - Kurth, Ann E.

AU - Cohen, Stephanie E.

AU - Mannheimer, Sharon B.

AU - Simmons, Janie

AU - Pouget, Enrique R.

AU - Trabold, Nicole

AU - Haberer, Jessica E.

PY - 2014/9/1

Y1 - 2014/9/1

N2 - Oral HIV pre-exposure prophylaxis (PrEP) is a promising new biomedical prevention approach in which HIV-negative individuals are provided with daily oral antiretroviral medication for the primary prevention of HIV-1. Several clinical trials have demonstrated efficacy of oral PrEP for HIV prevention among groups at high risk for HIV, with adherence closely associated with level of risk reduction. In the United States (US), three groups have been prioritized for initial implementation of PrEP - injection drug users, men who have sex with men at substantial risk for HIV, and HIV-negative partners within serodiscordant heterosexual couples. Numerous demonstration projects involving PrEP implementation among MSM are underway, but relatively little research has been devoted to study PrEP implementation in HIV-serodiscordant heterosexual couples in the US. Such couples face a unique set of challenges to PrEP implementation at the individual, couple, and provider level with regard to PrEP uptake and maintenance, adherence, safety and toxicity, clinical monitoring, and sexual risk behavior. Oral PrEP also provides new opportunities for serodiscordant couples and healthcare providers for primary prevention and reproductive health. This article provides a review of the critical issues, challenges, and opportunities involved in the implementation of oral PrEP among HIV-serodiscordant heterosexual couples in the US.

AB - Oral HIV pre-exposure prophylaxis (PrEP) is a promising new biomedical prevention approach in which HIV-negative individuals are provided with daily oral antiretroviral medication for the primary prevention of HIV-1. Several clinical trials have demonstrated efficacy of oral PrEP for HIV prevention among groups at high risk for HIV, with adherence closely associated with level of risk reduction. In the United States (US), three groups have been prioritized for initial implementation of PrEP - injection drug users, men who have sex with men at substantial risk for HIV, and HIV-negative partners within serodiscordant heterosexual couples. Numerous demonstration projects involving PrEP implementation among MSM are underway, but relatively little research has been devoted to study PrEP implementation in HIV-serodiscordant heterosexual couples in the US. Such couples face a unique set of challenges to PrEP implementation at the individual, couple, and provider level with regard to PrEP uptake and maintenance, adherence, safety and toxicity, clinical monitoring, and sexual risk behavior. Oral PrEP also provides new opportunities for serodiscordant couples and healthcare providers for primary prevention and reproductive health. This article provides a review of the critical issues, challenges, and opportunities involved in the implementation of oral PrEP among HIV-serodiscordant heterosexual couples in the US.

UR - http://www.scopus.com/inward/record.url?scp=84906238458&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84906238458&partnerID=8YFLogxK

U2 - 10.1089/apc.2013.0302

DO - 10.1089/apc.2013.0302

M3 - Article

C2 - 25045996

AN - SCOPUS:84906238458

VL - 28

SP - 462

EP - 474

JO - AIDS Patient Care and STDs

JF - AIDS Patient Care and STDs

SN - 1087-2914

IS - 9

ER -